Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion type Assertion NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_head.
- NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion description "[octreotide and lanreotide, normalizes circulating GH- and IGF-I levels in approximately 60-70% of acromegalic patients, thereby remaining about one-third of patients uncontrolled.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_provenance.
- NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion evidence source_evidence_literature NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_provenance.
- NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion SIO_000772 16625843 NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_provenance.
- NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion wasDerivedFrom befree-2016 NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_provenance.
- NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_assertion wasGeneratedBy ECO_0000203 NP545775.RA1HdGGHlQFGkD3v0o6R2olKLsDG27k5Uq7El_RQO_ARA130_provenance.